Physician profile
Charles Littlejohn
NPI 1831202738
$866.80
in general payments reported to CMS, 2019-2025
14 companies · $105 in 2025
The $105 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.82 · 2020: $127 · 2021: $220 · 2022: $155 · 2023: $170 · 2024: $18.83 · 2025: $105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $293.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $464.04 | 2021-2025 | |
| Ironshore Pharmaceuticals INC. | $75.66 | 2019-2023 | Jornay Pm |
| Axsome Therapeutics, INC. | $58.78 | 2025 | Auvelity |
| Allergan, INC. | $45.02 | 2020 | |
| Lilly USA, LLC | $41.45 | 2019-2021 | |
| Novo Nordisk INC | $32.85 | 2021-2023 | Ozempic, Rybelsus |
| Astellas Pharma US INC | $28.89 | 2019-2023 | Veozah |
| Amarin Pharma, INC. | $28.76 | 2020-2021 | |
| Dexcom, INC. | $18.88 | 2022 | |
| Sunovion Pharmaceuticals INC. | $15.69 | 2020 | |
| Glaxosmithkline, LLC. | $14.96 | 2020 | |
| Genentech USA, INC. | $14.25 | 2019 | |
| Pfizer INC. | $13.79 | 2025 | |
| Janssen Pharmaceuticals, INC | $13.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Littlejohn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.